To assess the efficacy and safety of the Ginkgo biloba extract in patients with Knee OA.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
60
120 mg leaf extract , twice daily in addition to Diclofenac 100 mg Once daily + paracetamol 1g Twice daily
placebo in addition to the standard treatment
Private Clinic
Najaf, N/A (Outside of US), Iraq
KOOS score
42 item questionnaire to assess pain, other symptoms, activities of daily living (ADL), sport and recreation function (Sport/Rec) and knee-related quality of life (QOL).
Time frame: Changes occured : baseline , 2 weeks , 4 weeks ,and 8 weeks
IL-6
Serum level of interleukin 6
Time frame: Changes occured: baseline , 4 weeks,and 8 weeks
TNF-alpha
Serum level of tumour necrosis factor - alpha
Time frame: Changes occured: baseline , 4 weeks,and 8 weeks
urinary CTX-II
C-terminal telopeptide of type II collagen from urine samples
Time frame: Changes occured :baseline , 4 weeks,and 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.